Contingency analysis of epidemiological, clinicopathological, and therapeutic characteristics in our cHL cohort with respect to their co-occurrence with SOCS1 mutations, or mutation subtypes, showed no significant differences or associations (Table 2). The gene discussed is SOCS1; the disease is classic Hodgkin lymphoma.